(Q81235302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Bent Deleuran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

David J Abraham

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

11 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Rheumatology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

682-683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

Systemic sclerosis: a prototypic multisystem fibrotic disorder

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Mechanisms and consequences of fibrosis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Is systemic sclerosis an antigen-driven T cell disease?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Increased interleukin-17 production in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

T(H)-17: a giant step from T(H)1 and T(H)2

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0618

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17848933%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference